Home›Companies›Healthcare›Bloodless Diagnostics

Bloodless Diagnostics Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Nov 10, 2026·Suggest an edit

About Bloodless Diagnostics

Bloodless Diagnostics is a private company based in Apex, North Carolina. It has reported $1,275,000 raised in one offering on Form D since November 2026. Its chief executive is Randy Allen.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 28, 2026Nov 10, 2026$1,275,000of $2.5M target1$1.2MSimple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bloodless Diagnostics's Form D filed Nov 10, 2026.

RA
Randy Allen
Chief Executive Officer and director
AS
Alan Staple
Executive officer and director

Sources

  1. SECBloodless Diagnostics Inc. filing history